Sanofi India appoints Preeti Futnani as GM of Vaccines

 6th June 2022    PR News 
 Soumiya Awasthi

Sanofi India today announced the appointment of Preeti Futnani as general manager – of vaccines, with effect from June 1, 2022. 

Futnani succeeds Annapurna Das, who is elevated to Head of Vaccines, Asia. Futnani will be based in Mumbai, India. 

Annapurna Das, the new head of Asia Vaccines said, “We are delighted to have Preeti Futnani join us as the GM for Vaccines in India. Her global experience is an asset that will further sharpen Sanofi India’s focus on increasing vaccine coverage rates by driving the growth of our current portfolio and accelerating the launch of innovative vaccines in the country. We wish her every success in this new role.”

Preeti Futnani, general manager, of Vaccines said, “Vaccines is a priority growth driver for Sanofi. I am excited to join the team and lead the next phase of ambition for the business in India. Together, we are committed to safeguarding the Indian population from vaccine-preventable diseases, at every stage of life, by leveraging the protective power of vaccination.”

She started her journey with Sanofi over six years ago in Specialty Care Gulf, after various roles of increasing responsibility in Novartis marketing and commercial operations across Switzerland, UK, and India.